Drugs / LH-001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06546449 | May 2025 → Jun 2027 expected | — | Chien-Liang Lin | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LH-001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06546449 ↗ |
| Route | Oral | “LH-001 will be administered oral” NCT06546449 ↗ |